Skip to main content
medichelpline
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis | Clinical Feed | MedicHelpline